Table 2. Comparison between groups of patients with indication versus no indication of PTX.
| Need of PTX (n = 251) | No need of PTX (n = 47) | |
| Male gender n (%) | 114 (45) | 24 (51) |
| Age (ys) | 47 (12.8) | 51.2 (16.5) |
| Diabetes n (%) | 27 (10.7) | 9 (19.1) |
| Hypertension n (%) | 139 (59.4) | 24 (58.5) |
| Ionized calcium (mg/dl) | 5.1 (3.7–7.1) | 5.2 (4.2–6) |
| Phosphorus (mg/dl) | 5.7 (1.6) | 4.9 (1.5)* |
| AP (U/L) | 262 (47–3215) | 105.5 (46–522)* |
| PTH (pg/ml) | 1457 (810–7368) | 241 (10–794)* |
| 25 vitamin D (ng/ml)# α | 24(3–93) | 27 (4–97) |
| Pain n (%) | 159 (67) | 17 (42.5) * |
| Fractures n (%) | 33 (13.9) | 4 (10) |
| On Calcitriol n (%) | 92 (39.6) | 19 (47.5) |
| Dialysis vintage (mo) | 72 (3–288) | 42 (3–168)* |
*
p<0.05 Data expressed as mean (SD), median (min-max), or number (percentage). PTH = parathormone. PXT = parathyroidectomy, AP = Alkaline phosphatase.
#
1 ng/mL = 2.5 nmol/L;
α
data available for 218 patients.